BAUSCH + LOMB CORP (BLCO) Stock Fundamental Analysis

NYSE:BLCO • CA0717051076

18.49 USD
-0.11 (-0.59%)
At close: Feb 26, 2026
18.85 USD
+0.36 (+1.95%)
After Hours: 2/26/2026, 8:12:26 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BLCO. BLCO was compared to 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of BLCO while its profitability can be described as average. BLCO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • BLCO had a positive operating cash flow in the past year.
  • In multiple years BLCO reported negative net income over the last 5 years.
  • Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO Yearly Net Income VS EBIT VS OCF VS FCFBLCO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of BLCO (-2.57%) is better than 69.19% of its industry peers.
  • BLCO's Return On Equity of -5.58% is fine compared to the rest of the industry. BLCO outperforms 69.73% of its industry peers.
  • With a decent Return On Invested Capital value of 1.23%, BLCO is doing good in the industry, outperforming 65.95% of the companies in the same industry.
  • BLCO had an Average Return On Invested Capital over the past 3 years of 1.34%. This is significantly below the industry average of 8.75%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.23%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
BLCO Yearly ROA, ROE, ROICBLCO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • BLCO has a Operating Margin of 3.69%. This is in the better half of the industry: BLCO outperforms 67.03% of its industry peers.
  • In the last couple of years the Operating Margin of BLCO has declined.
  • Looking at the Gross Margin, with a value of 59.81%, BLCO is in the better half of the industry, outperforming 61.08% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO Yearly Profit, Operating, Gross MarginsBLCO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • BLCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BLCO has more shares outstanding
  • BLCO has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BLCO has a worse debt to assets ratio.
BLCO Yearly Shares OutstandingBLCO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO Yearly Total Debt VS Total AssetsBLCO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.93, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.93, BLCO perfoms like the industry average, outperforming 51.35% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that BLCO is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.78, BLCO is doing worse than 69.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.93
ROIC/WACC0.12
WACC9.94%
BLCO Yearly LT Debt VS Equity VS FCFBLCO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • BLCO has a Current Ratio of 1.55. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO's Current ratio of 1.55 is on the low side compared to the rest of the industry. BLCO is outperformed by 73.51% of its industry peers.
  • BLCO has a Quick Ratio of 1.04. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO's Quick ratio of 1.04 is on the low side compared to the rest of the industry. BLCO is outperformed by 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO Yearly Current Assets VS Current LiabilitesBLCO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • BLCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -19.35%.
  • The Revenue has been growing slightly by 6.47% in the past year.
  • BLCO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.38% yearly.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • BLCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.47% yearly.
  • The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLCO Yearly Revenue VS EstimatesBLCO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO Yearly EPS VS EstimatesBLCO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 36.98 indicates a quite expensive valuation of BLCO.
  • 71.89% of the companies in the same industry are more expensive than BLCO, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.21, BLCO is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 22.97, BLCO is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, BLCO is valued a bit cheaper than 76.76% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.13. BLCO is around the same levels.
Industry RankSector Rank
PE 36.98
Fwd PE 22.97
BLCO Price Earnings VS Forward Price EarningsBLCO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLCO indicates a somewhat cheap valuation: BLCO is cheaper than 75.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.54
BLCO Per share dataBLCO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • BLCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BLCO's earnings are expected to grow with 40.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y47.19%
EPS Next 3Y40.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAUSCH + LOMB CORP

NYSE:BLCO (2/26/2026, 8:12:26 PM)

After market: 18.85 +0.36 (+1.95%)

18.49

-0.11 (-0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners11.05%
Inst Owner Change3.17%
Ins Owners0.45%
Ins Owner Change4.16%
Market Cap6.55B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts72.63
Price Target18.83 (1.84%)
Short Float %8.7%
Short Ratio10.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.97%
PT rev (3m)4.32%
EPS NQ rev (1m)3.86%
EPS NQ rev (3m)-1.08%
EPS NY rev (1m)0.21%
EPS NY rev (3m)0.88%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 36.98
Fwd PE 22.97
P/S 1.28
P/FCF N/A
P/OCF 23.15
P/B 1.02
P/tB N/A
EV/EBITDA 18.54
EPS(TTM)0.5
EY2.7%
EPS(NY)0.8
Fwd EY4.35%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)0.8
OCFY4.32%
SpS14.4
BVpS18.2
TBVpS-4.49
PEG (NY)0.61
PEG (5Y)N/A
Graham Number14.31
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.23%
ROICexc 1.27%
ROICexgc 4.04%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.34%
ROIC(5y)1.76%
ROICexc(3y)1.38%
ROICexc(5y)1.81%
ROICexgc(3y)4.6%
ROICexgc(5y)6.09%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.93
F-Score3
WACC9.94%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y60.98%
EPS Next 2Y47.19%
EPS Next 3Y40.75%
EPS Next 5Y32.47%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year5.85%
Revenue Next 2Y5.67%
Revenue Next 3Y5%
Revenue Next 5Y3.83%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y28.24%
EBIT Next 5Y16.65%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLCO.


What is the valuation status of BAUSCH + LOMB CORP (BLCO) stock?

ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO) has a profitability rating of 4 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO) is 1 / 10.